547 results on '"Kamphuisen, Pieter W."'
Search Results
2. Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study
3. Polygenic risk scores for prediction of cancer-associated venous thromboembolism in the UK Biobank cohort study
4. Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
5. Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancer
6. Platelet RNA sequencing for cancer screening in patients with unprovoked venous thromboembolism: a prospective cohort study
7. Treatment and prevention of cancer-associated thrombosis in the Netherlands: A national survey
8. Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
9. Pulmonary embolism at autopsy in cancer patients
10. Clinical history of cancer‐associated splanchnic vein thrombosis
11. Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study
12. Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study
13. Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
14. Heavy menstrual bleeding on direct factor Xa inhibitors: the MEDEA randomized clinical trial
15. Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles
16. Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism
17. Using Coronary Artery Calcium Score as Diagnostic Tool in Symptomatic Chronic Coronary Syndrome Patients in a Real-Life Setting
18. Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism
19. Prothrombotic state in patients with severe and prednisolone-dependent asthma
20. Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial
21. Using Coronary Artery Calcium Score as Diagnostic Tool in Symptomatic Chronic Coronary Syndrome Patients in a Real-Life Setting.
22. Analysis of an algorithm incorporating limited and whole-leg assessment of the deep venous system in symptomatic outpatients with suspected deep-vein thrombosis (PALLADIO): a prospective, multicentre, cohort study
23. Brief Report : Association Between Statin Use and Cardiovascular Mortality at the Population Level: An Ecologic Study
24. “ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
25. Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm
26. Bleeding complications during anticoagulant treatment in patients with cancer
27. Cardiovascular risk in patients with hemophilia
28. Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL
29. Abstract 15134: Comparison of Events Across Definitions of Major Bleeding in the Engage AF-TIMI 48 Trial
30. Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts
31. Bleeding Risk in Patients With Atrial Fibrillation: The AMADEUS Study
32. Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
33. Incidental venous thromboembolism in cancer patients: prevalence and consequence
34. Efficacy and Safety of Tinzaparin in CAT Patients with Hematological Malignancy
35. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial
36. Idarucizumab for Dabigatran Reversal
37. Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
38. Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal study
39. Optimization of the diagnostic management of clinically suspected pulmonary embolism in hospitalized patients
40. Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer
41. Acute pulmonary embolism. Part 2: treatment
42. Acute pulmonary embolism. Part 1: epidemiology and diagnosis
43. Age-Adjusted D-Dimer Cutoff Levels and Pulmonary Embolism—Reply
44. Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability, d-Dimer Testing, and Ultrasonography for Suspected Upper Extremity Deep Venous Thrombosis: A Prospective Management Study
45. Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism: The ADJUST-PE Study
46. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients
47. Clinical Impact of Findings Supporting an Alternative Diagnosis on CT Pulmonary Angiography in Patients With Suspected Pulmonary Embolism
48. Von Willebrand disease and other bleeding disorders in women:: consensus on diagnosis and management from an international expert panel
49. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
50. Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.